Considering the significant overlap observed between gene profiles of IFNα-exposed EndoC-βH1 cells and beta cells from T1D individuals (Supplementary Fig. 2d), mining these common signatures might identify relevant T1D therapeutic targets. This evidence concerns the gene IFNA17 and type 1 diabetes mellitus.